Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$7M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$105M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Welgus Howard G. | Sep 3, 2024 | Sell | 10,000 | $10.7695 | $110,000 |
| Burnett Patrick | Aug 19, 2024 | Sell | 1,728 | $8.286 | $14,000 |
| Burnett Patrick | Aug 2, 2024 | Sell | 13,206 | $9.0191 | $120,000 |
| Watanabe Todd Franklin | Aug 2, 2024 | Sell | 14,487 | $9.0183 | $130,000 |
| Matsuda Masaru | Aug 2, 2024 | Sell | 5,220 | $9.0161 | $47,000 |
| Welgus Howard G. | Aug 1, 2024 | Sell | 6,614 | $9.8696 | $65,000 |
| Welgus Howard G. | Aug 1, 2024 | Sell | 3,386 | $9.8696 | $33,000 |
| Welgus Howard G. | Jul 1, 2024 | Sell | 10,000 | $9.3141 | $93,000 |
| Welgus Howard G. | Jun 4, 2024 | Sell | 6,458 | $8.0142 | $52,000 |
| Welgus Howard G. | Jun 4, 2024 | Sell | 3,542 | $8 | $28,000 |
| Burnett Patrick | May 30, 2024 | Sell | 23,000 | $8.753 | $200,000 |
| Burnett Patrick | May 29, 2024 | Sell | 49,952 | $8.7161 | $440,000 |
| Matsuda Masaru | May 28, 2024 | Sell | 1,775 | $9.0074 | $16,000 |
| Edwards Larry Todd | May 17, 2024 | Sell | 7,640 | $8.9767 | $69,000 |
| Watanabe Todd Franklin | May 2, 2024 | Sell | 13,783 | $8.7378 | $120,000 |
| Moore Matthew Richard | May 2, 2024 | Sell | 4,681 | $8.7378 | $41,000 |
| Matsuda Masaru | May 2, 2024 | Sell | 5,016 | $8.7378 | $44,000 |
| Burnett Patrick | May 2, 2024 | Sell | 9,555 | $8.7378 | $83,000 |
| Watanabe Todd Franklin | Mar 4, 2024 | Sell | 14,903 | $11.1212 | $170,000 |
| Heron Patrick J | Mar 4, 2024 | Buy | 21,052 | $9.5 | $200,000 |
| Matsuda Masaru | Mar 4, 2024 | Sell | 3,760 | $11.1212 | $42,000 |
| Burnett Patrick | Mar 4, 2024 | Sell | 4,782 | $11.1212 | $53,000 |
| Moore Matthew Richard | Mar 4, 2024 | Sell | 3,468 | $11.1212 | $39,000 |
| Watanabe Todd Franklin | Feb 28, 2024 | Sell | 2,465 | $10.6 | $26,000 |
| Burnett Patrick | Jan 2, 2024 | Sell | 1,325 | $3.5408 | $4,700 |
| Matsuda Masaru | Nov 21, 2023 | Sell | 1,850 | $1.979 | $3,700 |
| Topper James N | Oct 24, 2023 | Buy | 80,000 | $2.5 | $200,000 |
| Burnett Patrick | Aug 21, 2023 | Sell | 1,305 | $7.04 | $9,200 |
| Burnett Patrick | Aug 21, 2023 | Sell | 300 | $7.05 | $2,100 |
| Watanabe Todd Franklin | May 31, 2023 | Buy | 1,463 | $6.38 | $9,300 |
| Matsuda Masaru | May 31, 2023 | Sell | 1,830 | $7.8023 | $14,000 |
| Welgus Howard G. | Apr 17, 2023 | Sell | 8,500 | $13.968 | $120,000 |
| Welgus Howard G. | Apr 6, 2023 | Sell | 8,500 | $12.01 | $100,000 |
| Watanabe Todd Franklin | Mar 6, 2023 | Sell | 2,435 | $15.2638 | $37,000 |
| Burrows Scott L | Mar 6, 2023 | Sell | 291 | $15.2634 | $4,400 |
| Burnett Patrick | Mar 6, 2023 | Sell | 851 | $15.2634 | $13,000 |
| Turney Patricia A. | Mar 6, 2023 | Sell | 831 | $15.2635 | $13,000 |
| OSBORNE DAVID W | Mar 6, 2023 | Sell | 690 | $15.2634 | $11,000 |
| Lock Kenneth A. | Mar 6, 2023 | Sell | 831 | $15.2636 | $13,000 |
| Moore Matthew Richard | Mar 2, 2023 | Sell | 1,589 | $15.8177 | $25,000 |
| Matsuda Masaru | Mar 2, 2023 | Sell | 1,416 | $15.8181 | $22,000 |
| Burnett Patrick | Mar 2, 2023 | Sell | 1,728 | $15.8178 | $27,000 |
| Turney Patricia A. | Mar 2, 2023 | Sell | 1,414 | $15.8183 | $22,000 |
| Watanabe Todd Franklin | Mar 2, 2023 | Sell | 5,403 | $15.8182 | $85,000 |
| Burrows Scott L | Mar 2, 2023 | Sell | 1,416 | $15.8183 | $22,000 |
| Lock Kenneth A. | Mar 2, 2023 | Sell | 1,414 | $15.8182 | $22,000 |
| OSBORNE DAVID W | Mar 2, 2023 | Sell | 1,198 | $15.8185 | $19,000 |
| Moore Matthew Richard | Mar 2, 2023 | Sell | 21 | $16.52 | $350 |
| Matsuda Masaru | Mar 2, 2023 | Sell | 18 | $16.52 | $300 |
| Burnett Patrick | Mar 2, 2023 | Sell | 23 | $16.52 | $380 |
| Turney Patricia A. | Mar 2, 2023 | Sell | 18 | $16.52 | $300 |
| Watanabe Todd Franklin | Mar 2, 2023 | Sell | 69 | $16.52 | $1,100 |
| Burrows Scott L | Mar 2, 2023 | Sell | 18 | $16.52 | $300 |
| Lock Kenneth A. | Mar 2, 2023 | Sell | 18 | $16.52 | $300 |
| OSBORNE DAVID W | Mar 2, 2023 | Sell | 15 | $16.52 | $250 |
| Watanabe Todd Franklin | Feb 28, 2023 | Sell | 2,343 | $16.1663 | $38,000 |
| Turney Patricia A. | Feb 28, 2023 | Sell | 936 | $16.1663 | $15,000 |
| Burrows Scott L | Feb 28, 2023 | Sell | 416 | $16.1663 | $6,700 |
| Lock Kenneth A. | Feb 28, 2023 | Sell | 936 | $16.1663 | $15,000 |
| OSBORNE DAVID W | Feb 28, 2023 | Sell | 792 | $16.1663 | $13,000 |
| Welgus Howard G. | Feb 15, 2023 | Sell | 8,500 | $16.9826 | $140,000 |
| Watanabe Todd Franklin | Feb 14, 2023 | Sell | 417 | $17.02 | $7,100 |
| Watanabe Todd Franklin | Feb 14, 2023 | Sell | 100 | $17.03 | $1,700 |
| Watanabe Todd Franklin | Feb 13, 2023 | Sell | 441 | $17 | $7,500 |
| Watanabe Todd Franklin | Feb 13, 2023 | Sell | 42 | $17.01 | $710 |
| Watanabe Todd Franklin | Feb 1, 2023 | Sell | 618 | $17.0044 | $11,000 |
| Watanabe Todd Franklin | Feb 1, 2023 | Sell | 382 | $17 | $6,500 |
| Welgus Howard G. | Jan 17, 2023 | Sell | 8,500 | $13.7241 | $120,000 |
| Burnett Patrick | Jan 3, 2023 | Sell | 1,475 | $15.0075 | $22,000 |
| Watanabe Todd Franklin | Dec 7, 2022 | Sell | 1,000 | $17.06 | $17,000 |
| Matsuda Masaru | Nov 21, 2022 | Sell | 1,720 | $18.1912 | $31,000 |
| Welgus Howard G. | Nov 15, 2022 | Sell | 3,403 | $20.0125 | $68,000 |
| Watanabe Todd Franklin | Nov 7, 2022 | Sell | 1,000 | $18.004 | $18,000 |
| Watanabe Todd Franklin | Oct 7, 2022 | Sell | 1,000 | $19.51 | $20,000 |
| Welgus Howard G. | Oct 4, 2022 | Sell | 6,000 | $20.2944 | $120,000 |
What's the latest insider transaction for Arcutis Biotherapeutics?
The most recent insider transaction for Arcutis Biotherapeutics was conducted by Welgus Howard G., who sold 10,000 shares on September 3, 2024 at a price of $10.77 per share.
Which insider bought the most ARQT stock over the last two years?
Topper James N has bought the most ARQT stock in the last 2 years, with a total value of $200,000.
Which insider has sold the most ARQT stock over the last two years?
Welgus Howard G. has sold the most ARQT stock in the last 2 years, with a total value of $1.1M.
What is the total value of insider transactions for Arcutis Biotherapeutics (ARQT) in the last 2 years?
The total value of insider transactions for Arcutis Biotherapeutics in the last 2 years is negative, amounting to -$2.9M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Arcutis Biotherapeutics' market confidence?
Over the last 2 years, insider transactions for Arcutis Biotherapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.